The specific aims of the trial were to test the effects of the established intervention compared with the advice only intervention;
the effects of the established plus DASH intervention compared with the advice only intervention; and the effects of the established plus DASH intervention compared with the established intervention.
The primary outcome was change in systolic BP from baseline to 6 months.
Hypertension status and change in diastolic BP at 6 months were secondary outcomes.
Blood pressure measurements were censored if the participant reported taking any anti hypertensive medication or other medications known to have major BP effects
(eg, oral steroids).
Hypertension was defined as a mean BP of 140/90mmHg or higher or use of anti hypertensive
medication.